Optometrists should perform a baseline dilated comprehensive eye examination on patients who take these medications for any reason to determine their pre-existing level of DR and whether they have any risk factors for developing NAION
Oral administration of bovine milk-derived extracellular vesicles induces senescence in the primary tumor but accelerates cancer metastasis
Key points: In the only head-to-head trial, Wegovy produced 15.8% weight loss compared with 6.4% for Saxenda over the same 68-week period Wegovy 7.2 mg (approved January 2026) produces even greater results at 20.7% average weight loss Real-world data from Second Nature shows 19.1% weight loss with semaglutide when combined with behavioural support Semaglutide participants were nearly three times more likely to achieve at least 10% weight loss than liraglutide participants Side effects and tolerability Both medications share a similar side-effect profile, predominantly affecting the gastrointestinal tract
Switching Between Wegovy Injection and Wegovy Tablets: Switching from the injection to the tablets: Patients taking the 2.4 mg dose of the injection for CV risk reduction or weight reduction may switch to the 25 mg tablets
A comprehensive array of B vitamins helps ensure your body has the metabolic support it needs, even when caloric intake is lower than usual
Documentation and Prescription Requirements Carry your original prescription label on the semaglutide pen or vial, along with a letter from your healthcare provider confirming the medication is medically necessary for your weight management treatment